163 related articles for article (PubMed ID: 12271408)
1. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.
de Jong IJ; Pruim J; Elsinga PH; Jongen MM; Mensink HJ; Vaalburg W
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1283-8. PubMed ID: 12271408
[TBL] [Abstract][Full Text] [Related]
2. Carbon-11 choline or FDG-PET for staging of oesophageal cancer?
Jager PL; Que TH; Vaalburg W; Pruim J; Elsinga P; Plukker JT
Eur J Nucl Med; 2001 Dec; 28(12):1845-9. PubMed ID: 11734925
[TBL] [Abstract][Full Text] [Related]
3. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
[TBL] [Abstract][Full Text] [Related]
4. Visualization of prostate cancer with 11C-choline positron emission tomography.
de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
Eur Urol; 2002 Jul; 42(1):18-23. PubMed ID: 12121724
[TBL] [Abstract][Full Text] [Related]
5. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.
Picchio M; Treiber U; Beer AJ; Metz S; Bössner P; van Randenborgh H; Paul R; Weirich G; Souvatzoglou M; Hartung R; Schwaiger M; Piert M
J Nucl Med; 2006 Jun; 47(6):938-44. PubMed ID: 16741302
[TBL] [Abstract][Full Text] [Related]
6. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Pieterman RM; Que TH; Elsinga PH; Pruim J; van Putten JW; Willemsen AT; Vaalburg W; Groen HJ
J Nucl Med; 2002 Feb; 43(2):167-72. PubMed ID: 11850480
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K
Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403
[TBL] [Abstract][Full Text] [Related]
8. 11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline.
Orevi M; Klein M; Mishani E; Chisin R; Freedman N; Gofrit ON
Clin Nucl Med; 2012 Apr; 37(4):e67-72. PubMed ID: 22391726
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
Golan S; Sopov V; Baniel J; Groshar D
J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of FDG PET in patients with cervical cancer.
Sugawara Y; Eisbruch A; Kosuda S; Recker BE; Kison PV; Wahl RL
J Nucl Med; 1999 Jul; 40(7):1125-31. PubMed ID: 10405131
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy.
Maurer T; Horn T; Souvatzoglou M; Eiber M; Beer AJ; Heck MM; Haller B; Gschwend JE; Schwaiger M; Treiber U; Krause BJ
Urol Int; 2014; 93(2):207-13. PubMed ID: 25012094
[TBL] [Abstract][Full Text] [Related]
14. Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
Chang JH; Lim Joon D; Davis ID; Lee ST; Hiew CY; Esler S; Gong SJ; Wada M; Clouston D; O'Sullivan R; Goh YP; Bolton D; Scott AM; Khoo V
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):438-45. PubMed ID: 25864171
[TBL] [Abstract][Full Text] [Related]
15. Detectability of residual invasive bladder cancer in delayed
Higashiyama A; Komori T; Juri H; Inada Y; Azuma H; Narumi Y
Ann Nucl Med; 2018 Oct; 32(8):561-567. PubMed ID: 30014439
[TBL] [Abstract][Full Text] [Related]
16. 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard.
Ceci F; Bianchi L; Graziani T; Castellucci P; Pultrone C; Eugenio B; Martorana G; Colletti PM; Rubello D; Fanti S; Schiavina R
Clin Nucl Med; 2015 Feb; 40(2):e124-8. PubMed ID: 25247272
[TBL] [Abstract][Full Text] [Related]
17. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.
Gofrit ON; Mishani E; Orevi M; Klein M; Freedman N; Pode D; Shapiro A; Katz R; Libson E; Chisin R
J Urol; 2006 Sep; 176(3):940-4; discussion 944. PubMed ID: 16890661
[TBL] [Abstract][Full Text] [Related]
18. 11C-choline PET/CT for restaging of bladder cancer.
Graziani T; Ceci F; Lopes FL; Chichero J; Castellucci P; Schiavina R; Bianchi L; Chondrogiannis S; Colletti PM; Costa S; Rubello D; Fanti S
Clin Nucl Med; 2015 Jan; 40(1):e1-5. PubMed ID: 25188643
[TBL] [Abstract][Full Text] [Related]
19. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
Hara T; Inagaki K; Kosaka N; Morita T
J Nucl Med; 2000 Sep; 41(9):1507-13. PubMed ID: 10994730
[TBL] [Abstract][Full Text] [Related]
20. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
